Company
Kura Oncology, Inc.
Kura Oncology, Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Ziftomenib | Phase 1 | Myelodysplastic Syndrome (MDS)/AML |
Latest
Follow Kura Oncology, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.